✦ LIBER ✦

Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension

✍ Scribed by Scott W. Klarenbach; Finlay A. McAlister; Helen Johansen; Karen Tu; Maureen Hazel; Robin Walker; Kelly B. Zarnke; Norman R.C. Campbell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

E5 Cost-effectiveness of first-line drug

✍ K.A. Pearce; C.D. Furberg; B.M. Psaty; J.K. Kirk 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Cost-effectiveness evaluation of sunitin

✍ Emiliano Calvo Aller; Pablo Maroto; Noémi Kreif; José Luis González Larriba; Mar 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 451 KB

PSS11 COST-EFFECTIVENESS ANALYSIS OF FOR

✍ D.A. Blaser; M.M. Ousterhout; J.M. Gagnon; D. Calabrese 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Cost-effectiveness projections of oxalip

✍ Bruce E. Hillner; Deborah Schrag; Daniel J. Sargent; Charles S. Fuchs; Richard M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

PCN88 Cost-Effectiveness Analysis Per Li

✍ C. Belda-Iniesta; V. Moreno; B. Martínez-Amores; J. Barriuso; L. Mezquita; I. Ib 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN71 Cost-Effectiveness Analysis of Cet

✍ V. Moreno; B. Martínez-Amores; J. Barriuso; L. Mezquita; I. Ibáñez de Cáceres; Á 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB